NCT02615808

Brief Summary

Hospitalized children with respiratory disease are commonly monitored with continuous pulse oximetry and heart rate-respiratory rate monitors. These data streams generate \>4,000 unique data points each patient-day, yet only a tiny fraction are used to inform care decisions. Failure to adequately summarize this large amount of data for clinicians may result in suboptimal care because clinicians may miss important data signals and may under- or over-react to individual data points. In children hospitalized with respiratory disease and in need of supplemental oxygen, there are a number of care decisions, currently made without adequate data, which could be informed by intelligent data visualization tools. This study has employed user-centered design to develop data displays that inform nurses' and respiratory therapists' decision-making in supplemental oxygen delivery. The investigators are now evaluating the effectiveness of these displays in the clinical care of patients with two common respiratory conditions-infants with bronchiolitis admitted to the general pediatrics ward and preterm infants requiring supplemental oxygen who are cared for in the neonatal intensive care unit. By reducing patient's time on supplemental oxygen and improving time with optimal oxygen saturations, this work has the potential to lead to a breakthrough innovation that improves both outcomes and value.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 26, 2015

Completed
Last Updated

July 26, 2016

Status Verified

July 1, 2016

First QC Date

November 24, 2015

Last Update Submit

July 25, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Time on supplemental oxygen (HM)

    6 months

  • Percent time within target saturation range (90-95%) (NICU)

    6 months

Secondary Outcomes (2)

  • Number of pulse oximetry alarms triggered (based on deviations from set range)

    6 months

  • Number of changes in oxygen flow or fractional inspired oxygen

    6 months

Study Arms (2)

Oxygen saturation data visualization

EXPERIMENTAL

During intervention periods staff in both units will have access to the data visualization tool in the electronic health record.

Other: Oxygen saturation data visualization

Control

NO INTERVENTION

During control periods, the staff will not have access to the data visualization and will continue to use standard of care electronic health record and monitor data to understand oxygen status and trends.

Interventions

The data visualization contains current and recent (over last 4, 8 or 12 hours) pulse oximetry readings and trends as well as the monitor alarm limits and most recently recorded supplemental oxygen content and flow.

Oxygen saturation data visualization

Eligibility Criteria

AgeUp to 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • patients with bronchiolitis (HM)
  • patients with supplemental oxygen need during hospitalization (HM)
  • patients \<12 months of age (HM)
  • patients \<32 weeks gestational age (NICU)
  • patients with consistent supplemental oxygen need in 48 hours prior to study entry (NICU)

You may not qualify if:

  • patients with supplemental oxygen need prior to admission (HM)
  • hospitalization occurs during the change from intervention to control periods (HM)
  • patients with congenital anomalies of the lung (NICU)
  • patients who are not in a weaning mode (e.g. on pre-discharge low flow oxygen) (NICU)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital Medical Center Burnet Campus

Cincinnati, Ohio, 45229, United States

Location

MeSH Terms

Conditions

Infant, Premature, DiseasesBronchiolitis

Condition Hierarchy (Ancestors)

Infant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBronchitisRespiratory Tract InfectionsInfectionsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung Diseases

Study Officials

  • Heather C Kaplan, MD, MSCE

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
  • Patrick W Brady, MD, MSc

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical research coordinator

Study Record Dates

First Submitted

November 24, 2015

First Posted

November 26, 2015

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

July 26, 2016

Record last verified: 2016-07

Locations